ADC Therapeutics (ADCT) is down -4.5%, or -16c to $3.43.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADCT:
- Biotech Alert: Searches spiking for these stocks today
- ADC Therapeutics’ Earnings Call: Clinical Wins Amid Challenges
- ADC Therapeutics Reports Q1 2025 Financial Results
- ADC announces data presentation from LOTIS-7 Phase 1b clinical trial
- ADC Therapeutics presents positive efficacy data from three ADCs at AACR 2025